We're still accepting applications for fall 2025!
Apply Today
The first Covid-19 vaccine expected to be deployed in the U.S. won the backing of a panel of government advisers, a step that will likely help clear the way for emergency authorization by the Food and Drug Administration.
Here are three key takeaways from the December 2 discussion on vaccine development with infectious disease expert and University of Michigan School of Public Health professor Arnold Monto.
Access to more localized data on childhood vaccination coverage, such as at the school or neighborhood levels, could help better predict and prevent measles outbreaks in the United States, according to a new University of Michigan study.
Arnold Monto, a leading epidemiologist at the University of Michigan's School of Public Health, will serve as acting chair of the Vaccines and Related committee Biological Products Advisory Committee meeting. The committee, which provides advice to the Food and Drug Administration, will discuss the development, authorization and licensure of vaccines to prevent COVID-19.
In Michigan, fewer than half of infants five months or younger are up to date on their vaccinations, which may allow for outbreaks of diseases like measles.
The scientific community agrees that a vaccine is essential to resuming anything resembling normal life. But on a societal level, vaccines only work if they’re widely adopted. Abram Wagner, research assistant professor of Epidemiology, explains.